Glenmark Marches To Different Drummer In Marketing Generics In U.S.
This article was originally published in PharmAsia News
Executive Summary
India’s Glenmark has departed from the local industry norm of marketing generics of best-selling drugs and will instead focus on niche drugs such as those for treating skin problems or oral contraceptives that do not have much competition.